| 1 | Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab (Darzalex) | [4]  Bortezomib Bortezomib, Cyclophosphamide, Daratumumab (Darzalex Sc), Dexamethasone | [5]  Cyclophosphamide 
                
                    Cyclophosphamide
                
            , 
                
                    Dexamethasone
                
            , 
                
                    Bortezomib
                
            , 
                
                    Cyclophosphamide
                
            , 
                
                    Daratumumab
                
             (Darzalex) 💬
 | [3]  CD38 CD38, NR3C1, PSMB5 💬
 | [16]  Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬 | [1]  28 28 💬
 | 
| 2 | Daratumumab (Darzalex) | [1]  Daratumumab Daratumumab (Darzalex Sc) | [1]  Daratumumab 
                
                    Daratumumab
                
             (Darzalex) 💬
 | [1]  CD38 CD38 💬
 | [7]  Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [5]  13 13, 28, 48, 49, 63 💬
 | 
| 3 | Daratumumab co-formulated with recombinant human hyaluronidase (rHuPH20) (Darzalex) | [3]  Daratumumab Daratumumab (Darzalex Sc), Hyaluronidase, Hyaluronidase (human recombinant) (Darzalex Faspro) | [4]  Hyaluronidase 
                
                    Hyaluronidase
                
            , 
                
                    Hyaluronidase
                
            , 
                
                    Hyaluronidase
                
            , 
                
                    Daratumumab
                
             (Darzalex) 💬
 | [1]  CD38 CD38 💬
 | [7]  Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1]  28 28 💬
 | 
| 4 | Daratumumab coformulato con ialuronidasi umana ricombinante (rHuPH20) (Darzalex) | [1]  Daratumumab Daratumumab (Darzalex Sc) | [1]  Daratumumab 
                
                    Daratumumab
                
             (Darzalex) 💬
 | [1]  CD38 CD38 💬
 | [7]  Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [1]  28 28 💬
 | 
| 5 | Daratumumab Injection (Darzalex) | [1]  Daratumumab Daratumumab (Darzalex Sc) | [1]  Daratumumab 
                
                    Daratumumab
                
             (Darzalex) 💬
 | [1]  CD38 CD38 💬
 | [7]  Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [3]  28 28, 49, 63 💬
 | 
| 6 | Darzalex | [1]  Daratumumab Daratumumab (Darzalex Sc) | [1]  Daratumumab 
                
                    Daratumumab
                
             (Darzalex) 💬
 | [1]  CD38 CD38 💬
 | [7]  Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | [3]  28 28, 49, 63 💬
 |